SVRA Savara, Inc. - Common Stock
$5,46
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$3–$7
62% of range
Analystenbewertung
BUY
14 analysts
Kursziel
$11
+100% upside
P/E (TTM)
-10.3
ROE
-73.4%
Nettogewinnmarge
—
SVRA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.46
Marktkapitalisierung
$1.12B
P/E (TTM)
-10.3
EPS (TTM)
$-0.53
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-73.4%
Verschuldungsgrad
0.1
52W-Spanne
$3 – $7
SVRA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2016-12-31
→
2020-12-31
EPS
$-0.53
2021-12-31
→
2025-12-31
Freier Cashflow
$-101M
2016-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
SVRA
Peer-Median
P/E (TTM)
-10.3
—
P/B (K/B)
5.5
5.2
EV / EBITDA
-7.4
—
Price / FCF (Kurs / FCF)
-11.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
SVRA
Peer-Median
ROA
-51.0%
-44.7%
ROE
-73.4%
-51.5%
ROIC
-53.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
SVRA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.1
0.0
Current Ratio (Liquiditätsgrad)
11.8
9.5
Quick Ratio
11.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
SVRA
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
SVRA
Peer-Median
SVRA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 5 35,7%
- Kauf 8 57,1%
- Halten 1 7,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-17
Median
$10.25
Mittelwert
$10.94
← Unter allen Zielen
$5.46
Tief
$9.00
Hoch
$16.00
Median-Ziel
$10.25
+87,7%
Mittelwert-Ziel
$10.94
+100,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.15 | $-0.14 | -0.01% |
| 31. Dezember 2025 | $-0.13 | $-0.12 | -0.01% |
| 30. September 2025 | $-0.14 | $-0.14 | -0.00% |
| 30. Juni 2025 | $-0.14 | $-0.12 | -0.02% |
| 31. März 2025 | $-0.12 | $-0.13 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| ODTX | — | — | — | — | — | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $257.0K | $0 | · | $0 | $400.0K | $54.0K | $0 | |
| SG&A Expense | $42M | $25M | $16M | $11M | $12M | $14M | $13M | $11M | $11M | $3M | $2M | $9M | |
| Operating Expenses | $124M | $103M | $60M | $39M | $41M | $50M | $79M | $70M | $30M | $11M | $6M | $29M | |
| Operating Income | $-124M | $-103M | $-60M | $-39M | $-41M | $-49M | $-79M | $-70M | $-30M | $-11M | $-6M | $-29M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1M | $452.0K | $3M | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $122.0K | $130.0K | $69.0K | |
| Other Non-op | $5M | $7M | $5M | $689.0K | $-2M | $-315.0K | $852.0K | $1M | $-3M | $-332.0K | $-3M | $508.0K | |
| Pretax Income | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-69M | $-33M | $-11M | $-9M | $-29M | |
| Income Tax | $0 | $9.0K | · | · | · | · | · | $-7M | $-4M | $-357.0K | $0 | $0 | |
| Net Income | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-62M | $-30M | $-11M | $-9M | $-29M | |
| EPS (Basic) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · | |
| Shares (Basic) | 222,387,531 | 198,191,936 | 165,204,652 | 152,771,817 | 133,919,145 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 222,387,531 | 198,191,936 | 165,204,652 | 152,771,817 | 133,919,145 | · | · | · | · | · | · | · | |
| EBITDA | $-124M | · | $-60M | $-39M | $-41M | $-49M | $-78M | $-70M | $-30M | $-36M | $-39M | $-29M |
Bilanz 25
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33M | $15M | $27M | $52M | $34M | $23M | $50M | $24M | $22M | $13M | $17M | $13M | |
| Short-term Investments | $203M | $181M | $136M | $74M | $127M | $59M | $72M | $87M | $72M | $0 | · | · | |
| Prepaid Expense | $6M | $6M | $4M | $3M | $4M | $3M | $2M | $3M | $4M | $840.0K | $1M | $1M | |
| Current Assets | $242M | $202M | $166M | $129M | $165M | $85M | $124M | $113M | $98M | $15M | $42M | $58M | |
| PP&E (Net) | $100.0K | $165.0K | $270.0K | $51.0K | $73.0K | $156.0K | $352.0K | $522.0K | $925.0K | $793.0K | $226.0K | $188.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $565.0K | $532.0K | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $851.0K | $504.0K | $339.0K | $344.0K | |
| Goodwill | · | · | · | · | · | $0 | · | $27M | $27M | $3M | $3M | $3M | |
| Other Non-current Assets | $84.0K | $242.0K | $387.0K | $116.0K | $251.0K | $250.0K | $673.0K | $131.0K | $131.0K | $131.0K | $183.0K | $353.0K | |
| Total Assets | $253M | $213M | $178M | $140M | $177M | $98M | $136M | $152M | $160M | $29M | $54M | $70M | |
| Accounts Payable | $6M | $5M | $4M | $1M | $1M | $3M | $3M | $4M | $3M | $536.0K | $3M | $1M | |
| Accrued Liabilities | $15M | $10M | $7M | $5M | $5M | $6M | $5M | $3M | $3M | $2M | $8M | $6M | |
| Current Liabilities | $20M | $15M | $11M | $6M | $15M | $8M | $11M | $7M | $6M | $3M | $23M | $8M | |
| Capital Leases | · | $100.0K | $200.0K | $50.0K | $100.0K | $100.0K | $300.0K | · | $297.0K | $579.0K | $25.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $7M | $2M | $3M | $3M | |
| Other Non-current Liabilities | $0 | $87.0K | $247.0K | $54.0K | $117.0K | $84.0K | $513.0K | $70.0K | · | · | · | · | |
| Total Liabilities | $50M | $41M | $37M | $32M | $32M | $33M | $35M | $44M | $40M | $21M | $30M | $12M | |
| Long-term Debt | $30M | $27M | $26M | $26M | $26M | $25M | · | · | · | · | · | · | |
| Total Debt | $30M | · | $26M | $26M | $26M | · | · | · | · | · | · | · | |
| Common Stock | $204.0K | $173.0K | $140.0K | $116.0K | $116.0K | $55.0K | $52.0K | $36.0K | $32.0K | $5.0K | $164.0K | $159.0K | |
| Retained Earnings | $-608M | $-489M | $-393M | $-339M | $-301M | $-258M | $-208M | $-130M | $-68M | $-38M | $-275M | $-235M | |
| AOCI | $-87.0K | $-750.0K | $-271.0K | $-605.0K | $5.0K | $942.0K | $-17.0K | $200.0K | $958.0K | $-591.0K | $-17.0K | $-25.0K | |
| Stockholders' Equity | $203M | $171M | $140M | $108M | $144M | $64M | $102M | $108M | $119M | $-36M | $-27M | $-18M | |
| Liabilities + Equity | $253M | $213M | $178M | $140M | $177M | $98M | $136M | $152M | $160M | $29M | $54M | $70M | |
| Shares Outstanding | 204,567,283 | 172,423,223 | 138,143,545 | 114,046,345 | 114,036,892 | 54,152,955 | 50,790,441 | 35,146,096 | 30,509,522 | 3,162,573 | 163,614,297 | 159,458,376 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $130.0K | $77.0K | $31.0K | $136.0K | $255.0K | $1M | $526.0K | · | $99.0K | $146.0K | $85.0K | |
| Stock-based Comp | $14M | $10M | $4M | $2M | $3M | $5M | $4M | $4M | $552.0K | $209.0K | $153.0K | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $-7M | $-3M | $-2M | · | · | |
| Other Non-cash | · | · | · | · | · | · | $28M | · | · | · | · | · | |
| Operating Cash Flow | $-101M | $-89M | $-51M | $-35M | $-40M | $-40M | $-45M | $-39M | $-28M | $-8M | $-5M | $-25M | |
| CapEx | $22.0K | $25.0K | $296.0K | $9.0K | $57.0K | $47.0K | $148.0K | $141.0K | $495.0K | $8.0K | $165.0K | $147.0K | |
| Investing Cash Flow | $-18M | $-40M | $-57M | $53M | $-69M | $9M | $16M | $-14M | $-69M | · | · | · | |
| Debt Issued | $30M | · | · | $26M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $2M | · | · | $88.0K | · | · | · | · | $-4M | · | · | · | |
| Stock Issued | · | · | · | · | · | $2M | $30M | $505.0K | $2M | $20M | $2M | $30M | |
| Net Stock Activity | · | · | · | · | · | $2M | $30M | $505.0K | $2M | $20M | $2M | $30M | |
| Financing Cash Flow | $138M | $118M | $83M | $87.0K | $121M | $4M | $55M | $55M | $106M | · | · | · | |
| Net Change in Cash | $18M | $-11M | $-26M | $18M | $11M | $-27M | $26M | $2M | $9M | $-3M | $4M | $10M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-101M | · | $-51M | $-35M | $-40M | $-40M | $-45M | $-39M | $-29M | $-37M | $-33M | $-25M | |
| Levered FCF | · | · | · | · | · | · | · | · | $-30M | $-39M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -19182.9% | · | · | · | -28481.2% | · | · | |
| Net Margin | · | · | · | · | · | -19305.5% | · | · | · | -28203.1% | · | · | |
| Pretax Margin | · | · | · | · | · | -19305.5% | · | · | · | -30085.2% | · | · | |
| EBITDA Margin | · | · | · | · | · | -19182.9% | · | · | · | -28481.2% | · | · | |
| ROA | -51.0% | · | -34.5% | -24.1% | -31.4% | -42.4% | -54.2% | -39.4% | -31.6% | -100.1% | -63.9% | -45.6% | |
| ROE | -73.4% | · | -38.1% | -34.0% | -28.7% | -70.4% | -75.0% | -54.4% | -71.4% | 410.9% | -1425.5% | -53.9% | |
| ROIC | -53.0% | · | · | · | · | · | · | -56.9% | -22.4% | -350.2% | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | 15.7 | 22.0 | 11.3 | 10.4 | 11.4 | 15.6 | 16.3 | 2.5 | 1.8 | 6.9 | |
| Quick Ratio | 11.6 | · | 15.3 | 21.5 | 11.0 | 10.1 | 11.2 | 15.3 | 15.7 | 1.8 | 1.0 | 4.2 | |
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.2 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.1 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -25.8 | -17.1 | -65.3 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
Bewertung (TTM) 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $257.0K | $0 | · | $0 | $400.0K | $54.0K | $0 | |
| Net Income TTM | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-62M | $-30M | $-11M | $-9M | $-29M | |
| Market Cap | $1.23B | · | $649M | $177M | $141M | $62M | $228M | $266M | $453M | · | · | · | |
| Enterprise Value | $1.03B | · | $513M | $77M | $6M | · | · | · | · | · | · | · | |
| P/E | -11.4 | -6.4 | -14.2 | -6.2 | -3.9 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 242.3 | · | · | · | · | · | · | |
| P/B | 6.1 | · | 4.6 | 1.6 | 1.0 | 1.0 | 2.2 | 2.5 | 3.8 | · | · | · | |
| P / Tangible Book | 6.1 | 3.1 | 4.6 | 1.6 | 1.0 | 1.0 | · | · | · | · | · | · | |
| P / Cash Flow | -12.2 | · | -12.7 | -5.1 | -3.5 | -1.6 | -5.0 | -6.8 | -16.0 | · | · | · | |
| P / FCF | -12.2 | · | -12.6 | -5.1 | -3.5 | -1.6 | -5.0 | -6.7 | -15.8 | · | · | · | |
| EV / EBITDA | -8.3 | · | -8.6 | -2.0 | -0.1 | · | · | · | · | · | · | · | |
| EV / FCF | -10.2 | · | -10.0 | -2.2 | -0.1 | · | · | · | · | · | · | · | |
| Earnings Yield | -8.8% | -15.6% | -7.0% | -16.1% | -25.8% | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $19M | $16M | $13M | $10M | $11M | $9M | $8M | $6M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $2M | |
| Operating Expenses | $41M | $39M | $33M | $30M | $31M | $28M | $31M | $26M | $23M | $22M | $18M | $18M | $12M | $12M | $11M | $11M | |
| Operating Income | $-41M | $-39M | $-33M | $-30M | $-31M | $-28M | $-31M | $-26M | $-23M | $-22M | $-18M | $-18M | $-12M | $-12M | $-11M | $-11M | |
| Other Non-op | $737.0K | $2M | $1M | $694.0K | $1M | $2M | $2M | $2M | $947.0K | $2M | $2M | $1M | $778.0K | $2M | $575.0K | $149.0K | |
| Pretax Income | · | · | · | · | · | $-27M | · | · | · | $-20M | · | · | · | · | · | · | |
| Net Income | $-40M | $-37M | $-32M | $-30M | $-30M | $-27M | $-29M | $-24M | $-22M | $-20M | $-16M | $-17M | $-11M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.16 | $-0.15 | $-0.13 | $-0.14 | $-0.14 | $-0.12 | $-0.14 | $-0.11 | $-0.12 | $-0.11 | $-0.09 | $-0.10 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | |
| EPS (Diluted) | $-0.16 | $-0.15 | $-0.13 | $-0.14 | $-0.14 | $-0.12 | $-0.14 | $-0.11 | $-0.12 | $-0.11 | $-0.09 | $-0.10 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | |
| Shares (Basic) | 253,569,891 | 253,280,551 | -426,652,912 | 216,462,161 | 216,431,348 | 216,146,934 | -378,789,902 | 211,847,651 | 182,584,078 | 182,550,109 | -315,069,736 | 174,696,191 | 152,796,617 | 152,781,580 | -305,541,525 | 152,773,015 | |
| Shares (Diluted) | 253,569,891 | 253,280,551 | -426,652,912 | 216,462,161 | 216,431,348 | 216,146,934 | -378,789,902 | 211,847,651 | 182,584,078 | 182,550,109 | -315,069,736 | 174,696,191 | 152,796,617 | 152,781,580 | -305,541,525 | 152,773,015 | |
| EBITDA | $-41M | $-39M | · | $-30M | $-31M | $-28M | · | $-26M | $-23M | $-22M | · | $-18M | $-12M | $-12M | · | $-11M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $42M | $39M | $33M | $16M | $17M | $20M | $15M | $21M | $24M | $17M | $27M | $28M | $23M | $34M | $52M | $120M | |
| Short-term Investments | $131M | $164M | $203M | $108M | $129M | $153M | $181M | $198M | $98M | $126M | $136M | $141M | $82M | $81M | $74M | $14M | |
| Prepaid Expense | $5M | $6M | $6M | $4M | $5M | $5M | $6M | $7M | $6M | $3M | $4M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $178M | $209M | $242M | $128M | $151M | $177M | $202M | $226M | $128M | $146M | $166M | $170M | $108M | $118M | $129M | $137M | |
| PP&E (Net) | $641.0K | $130.0K | $100.0K | $85.0K | $119.0K | $138.0K | $165.0K | $206.0K | $236.0K | $248.0K | $270.0K | $277.0K | $264.0K | $47.0K | $51.0K | $59.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Other Non-current Assets | $2M | $886.0K | $84.0K | $990.0K | $1M | $1M | $242.0K | $1M | $1M | $1M | $387.0K | $1M | $888.0K | $868.0K | $116.0K | $876.0K | |
| Total Assets | $192M | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M | $158M | $178M | $182M | $120M | $129M | $140M | $148M | |
| Accounts Payable | $7M | $4M | $6M | $4M | $5M | $6M | $5M | $5M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $893.0K | |
| Accrued Liabilities | $11M | $11M | $15M | $13M | $9M | $6M | $10M | $8M | $8M | $7M | $7M | $6M | $3M | $3M | $5M | $4M | |
| Current Liabilities | $18M | $16M | $20M | $17M | $14M | $12M | $15M | $13M | $11M | $10M | $11M | $9M | $6M | $5M | $6M | $5M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $300.0K | · | · | · | · | |
| Other Non-current Liabilities | $770.0K | · | $0 | $0 | $0 | $44.0K | $87.0K | $128.0K | $169.0K | $208.0K | $247.0K | $284.0K | $20.0K | $37.0K | $54.0K | $71.0K | |
| Total Liabilities | $48M | $46M | $50M | $47M | $43M | $41M | $41M | $39M | $38M | $36M | $37M | $36M | $32M | $31M | $32M | $31M | |
| Long-term Debt | $30M | $30M | $30M | $30M | $30M | $30M | · | $27M | $26M | $26M | · | $26M | $26M | $26M | · | $26M | |
| Total Debt | $30M | $30M | · | $30M | $30M | $30M | · | $27M | $26M | $26M | · | $26M | $26M | $26M | · | $26M | |
| Common Stock | $204.0K | $204.0K | $204.0K | $173.0K | $173.0K | $173.0K | $173.0K | $172.0K | $140.0K | $140.0K | $140.0K | $137.0K | $116.0K | $116.0K | $116.0K | $116.0K | |
| Retained Earnings | $-686M | $-645M | $-608M | $-576M | $-546M | $-516M | $-489M | $-460M | $-436M | $-414M | $-393M | $-377M | $-361M | $-349M | $-339M | $-328M | |
| AOCI | $-534.0K | $-429.0K | $-87.0K | $-155.0K | $-216.0K | $-632.0K | $-750.0K | $299.0K | $-880.0K | $-742.0K | $-271.0K | $-942.0K | $-619.0K | $-461.0K | $-605.0K | $-2M | |
| Stockholders' Equity | $144M | $176M | $203M | $94M | $120M | $148M | $171M | $199M | $102M | $122M | $140M | $147M | $88M | $98M | $108M | $117M | |
| Liabilities + Equity | $192M | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M | $158M | $178M | $182M | $120M | $129M | $140M | $148M | |
| Shares Outstanding | 205,399,365 | 204,922,140 | 204,567,283 | 172,850,443 | 172,836,922 | 172,703,390 | 172,423,223 | 170,842,763 | 138,199,047 | 138,176,641 | 138,143,545 | 135,339,836 | 114,150,455 | 114,064,736 | 114,046,345 | 114,042,642 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $28.0K | $24.0K | $-13.0K | $35.0K | $34.0K | $30.0K | $32.0K | $33.0K | $33.0K | $32.0K | $31.0K | $30.0K | $8.0K | $8.0K | $7.0K | $8.0K | |
| Stock-based Comp | $8M | $11M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $995.0K | $958.0K | $864.0K | $561.0K | $450.0K | |
| Operating Cash Flow | $-30M | $-33M | $-25M | $-23M | $-26M | $-27M | $-23M | $-23M | $-22M | $-21M | $-16M | $-13M | $-10M | $-12M | $-9M | $-8M | |
| CapEx | $222.0K | $54.0K | $2.0K | $2.0K | $15.0K | $3.0K | $-9.0K | $3.0K | $21.0K | $10.0K | $24.0K | $43.0K | $225.0K | $4.0K | $0 | $4.0K | |
| Investing Cash Flow | $33M | $39M | $-94M | $21M | $24M | $29M | $18M | $-98M | $30M | $11M | $7M | $-57M | $-1M | $-6M | $-59M | $33M | |
| Debt Issued | · | · | $0 | $0 | $0 | $30M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $189.0K | $-195.0K | $136M | $-23.0K | $-49.0K | $2M | $-843.0K | $118M | $55.0K | $49.0K | $8M | $75M | $104.0K | $26.0K | $1.0K | $-1.0K | |
| Net Change in Cash | $3M | $6M | $17M | $-1M | $-2M | $4M | $-6M | $-2M | $7M | $-10M | $-1M | $5M | $-11M | $-18M | $-68M | $25M | |
| Free Cash Flow | · | $-33M | · | · | · | $-27M | · | · | · | $-21M | · | · | · | $-12M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -22.6% | -18.1% | · | -15.6% | -20.0% | -15.3% | · | -11.5% | -17.1% | -14.1% | · | -10.1% | -8.3% | -7.1% | · | -6.2% | |
| ROE | -30.5% | -23.0% | · | -20.1% | -27.4% | -19.8% | · | -14.0% | -23.5% | -18.5% | · | -12.6% | -10.7% | -9.0% | · | -7.6% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 13.5 | · | 7.7 | 11.1 | 14.9 | · | 17.7 | 11.3 | 14.9 | · | 19.0 | 18.3 | 23.9 | · | 26.5 | |
| Quick Ratio | 9.8 | 13.0 | · | 7.4 | 10.7 | 14.5 | · | 17.2 | 10.8 | 14.6 | · | 18.8 | 17.9 | 23.3 | · | 26.0 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.2 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.2 |
Bewertung (TTM) 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-137M | $-124M | · | $-111M | $-104M | $-93M | · | $-83M | $-71M | $-59M | · | $-49M | $-42M | $-38M | · | $-38M | |
| Market Cap | $1.27B | $1.12B | · | $617M | $394M | $478M | · | $724M | $557M | $688M | · | $512M | $365M | $222M | · | $177M | |
| Enterprise Value | $1.12B | $946M | · | $522M | $277M | $335M | · | $531M | $462M | $571M | · | $370M | $286M | $134M | · | $69M | |
| P/E | -10.4 | -9.9 | · | -7.0 | -4.7 | -6.0 | · | -9.6 | -10.1 | -14.2 | · | -12.2 | -11.8 | -7.8 | · | -6.2 | |
| P/B | 8.8 | 6.4 | · | 6.5 | 3.3 | 3.2 | · | 3.6 | 5.5 | 5.6 | · | 3.5 | 4.2 | 2.3 | · | 1.5 | |
| P / Tangible Book | 8.8 | 6.4 | · | 6.5 | 3.3 | 3.2 | · | 3.6 | 5.5 | 5.6 | · | 3.5 | 4.2 | 2.3 | · | 1.5 | |
| P / Cash Flow | · | -33.9 | · | · | · | -17.6 | · | · | · | -33.3 | · | · | · | -18.5 | · | · | |
| P / FCF | · | -33.8 | · | · | · | -17.6 | · | · | · | -33.3 | · | · | · | -18.5 | · | · | |
| EV / EBITDA | -27.4 | -24.3 | · | -17.3 | -8.8 | -11.8 | · | -20.2 | -19.9 | -25.4 | · | -20.5 | -23.4 | -11.0 | · | -6.5 | |
| EV / FCF | · | -28.6 | · | · | · | -12.3 | · | · | · | -27.7 | · | · | · | -11.1 | · | · | |
| Earnings Yield | -9.6% | -10.1% | · | -14.3% | -21.5% | -16.6% | · | -10.4% | -9.9% | -7.0% | · | -8.2% | -8.5% | -12.8% | · | -16.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-119M | $-96M | $-55M | $-38M | $-43M |
| Verwässerte EPS | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.1 | — | 0.2 | 0.2 | 0.2 |
| Liquiditätsgrad | 11.8 | — | 15.7 | 22.0 | 11.3 |
| Quick Ratio | 11.6 | — | 15.3 | 21.5 | 11.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-101M | — | $-51M | $-35M | $-40M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 197 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (-23 vs. Vorquartal) | 25 (+6 vs. Vorquartal) | 69 (+7 vs. Vorquartal) | 54 (+13 vs. Vorquartal) | +12.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| NEA Management Company, LLC | $150.742.986 | 24.471.264 | 12,35% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $108.419.826 | 17.600.621 | 8,88% | Aktien |
| Venrock Adviser, LLC | $90.835.009 | 14.745.943 | 7,44% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $83.585.040 | 13.569.000 | 6,85% | Aktien |
| TCG Crossover Management, LLC | $76.151.183 | 12.362.205 | 6,24% | Aktien |
| Frazier Life Sciences Management, L.P. | $59.880.448 | 9.720.852 | 4,90% | Aktien |
| Polar Capital Holdings Plc | $58.777.402 | 9.541.786 | 4,81% | Aktien |
| VANGUARD GROUP INC | $54.222.146 | 8.992.064 | 4,44% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $48.864.477 | 7.932.545 | 4,00% | Aktien |
| Nantahala Capital Management, LLC | $42.977.150 | 6.976.810 | 3,52% | Aktien |
| STATE STREET CORP | $40.368.624 | 6.553.348 | 3,31% | Aktien |
| RTW INVESTMENTS, LP | $36.666.661 | 5.952.380 | 3,00% | Aktien |
| Woodline Partners LP | $26.149.933 | 4.245.119 | 2,14% | Aktien |
| ORBIMED ADVISORS LLC | $24.392.984 | 3.959.900 | 2,00% | Aktien |
| Spruce Street Capital LP | $21.267.868 | 3.452.576 | 1,74% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $20.600.575 | 3.343.378 | 1,69% | Aktien |
| Rosalind Advisors, Inc. | $19.577.225 | 3.178.121 | 1,60% | Aktien |
| EMERALD ADVISERS, LLC | $19.394.384 | 3.148.439 | 1,59% | Aktien |
| Pictet Asset Management Holding SA | $17.020.419 | 2.763.055 | 1,39% | Aktien |
| Vestal Point Capital, LP | $16.755.200 | 2.720.000 | 1,37% | Aktien |
| Affinity Asset Advisors, LLC | $15.474.862 | 2.512.153 | 1,27% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $14.636.154 | 2.375.999 | 1,20% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $11.348.876 | 1.842.350 | 0,93% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.076.762 | 1.635.838 | 0,83% | Aktien |
| ADAR1 Capital Management, LLC | $8.644.999 | 1.403.409 | 0,71% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8.349.627 | 1.355.459 | 0,68% | Aktien |
| ALGERT GLOBAL LLC | $8.188.235 | 1.329.259 | 0,67% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $7.417.447 | 1.204.131 | 0,61% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.211.802 | 1.170.747 | 0,59% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.412.597 | 1.041.006 | 0,53% | Aktien |
| Longaeva Partners L.P. | $6.257.864 | 1.015.887 | 0,51% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $6.021.154 | 977.460 | 0,49% | Aktien |
| MARSHALL WACE, LLP | $5.458.967 | 886.196 | 0,45% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $4.657.970 | 756.164 | 0,38% | Aktien |
| Swedbank AB | $4.409.944 | 715.900 | 0,36% | Aktien |
| F/m Investments LLC | $4.055.461 | 658.354 | 0,33% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.891.144 | 631.679 | 0,32% | Aktien |
| Sio Capital Management, LLC | $3.804.878 | 617.675 | 0,31% | Aktien |
| AXA Investment Managers S.A. | $3.760.142 | 1.053.261 | 0,31% | Aktien |
| KVP Capital Advisors, LP | $3.728.525 | 605.280 | 0,31% | Aktien |
| Integral Health Asset Management, LLC | $3.696.000 | 600.000 | 0,30% | Aktien |
| D. E. Shaw & Co., Inc. | $3.120.890 | 506.638 | 0,26% | Aktien |
| Moody Aldrich Partners LLC | $2.974.005 | 482.793 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.811.837 | 456.467 | 0,23% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.529.351 | 410.609 | 0,21% | Aktien |
| Sofinnova Investments, Inc. | $2.246.940 | 364.763 | 0,18% | Aktien |
| Seven Fleet Capital Management LP | $1.904.074 | 309.103 | 0,16% | Aktien |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1.681.669 | 307.998 | 0,14% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.533.156 | 248.889 | 0,13% | Aktien |
| Walleye Capital LLC | $1.532.115 | 248.720 | 0,13% | Aktien |
| HighVista Strategies LLC | $1.493.054 | 242.379 | 0,12% | Aktien |
| Eversept Partners, LP | $1.259.276 | 204.428 | 0,10% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.236.693 | 205.090 | 0,10% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $1.205.851 | 195.755 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $1.146.187 | 186.071 | 0,09% | Aktien |
| Swiss National Bank | $1.139.600 | 185.000 | 0,09% | Aktien |
| FMR LLC | $1.064.676 | 172.837 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $1.053.797 | 171.071 | 0,09% | Aktien |
| CITIGROUP INC | $923.335 | 149.892 | 0,08% | Aktien |
| Jain Global LLC | $879.605 | 142.793 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $859.708 | 139.563 | 0,07% | Aktien |
| XTX Topco Ltd | $754.662 | 122.510 | 0,06% | Aktien |
| GLENMEDE TRUST CO NA | $707.432 | 114.843 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $693.638 | 127.040 | 0,06% | Aktien |
| BlackRock, Inc. | $646.196 | 104.902 | 0,05% | Aktien |
| DCF Advisers, LLC | $616.000 | 100.000 | 0,05% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $585.921 | 95.117 | 0,05% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $574.728 | 93.300 | 0,05% | Kaufoption |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $554.400 | 90.000 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $549.817 | 89.256 | 0,05% | Aktien |
| Bank of New York Mellon Corp | $549.330 | 89.177 | 0,04% | Aktien |
| Rafferty Asset Management, LLC | $547.279 | 88.844 | 0,04% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $531.534 | 86.288 | 0,04% | Aktien |
| Cresset Asset Management, LLC | $513.337 | 83.334 | 0,04% | Aktien |
| MORGAN STANLEY | $496.096 | 80.535 | 0,04% | Aktien |
| Birchview Capital, LP | $492.800 | 80.000 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $473.291 | 76.833 | 0,04% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $461.236 | 74.876 | 0,04% | Aktien |
| Optimize Financial Inc | $459.202 | 84.103 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $432.130 | 70.151 | 0,04% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $430.492 | 69.885 | 0,04% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $405.427 | 65.816 | 0,03% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $388.560 | 63.078 | 0,03% | Aktien |
| Virtus Investment Advisers, LLC | $383.183 | 62.205 | 0,03% | Aktien |
| JPMORGAN CHASE & CO | $382.459 | 63.426 | 0,03% | Aktien |
| Verdad Advisers, LP | $380.435 | 61.759 | 0,03% | Aktien |
| Invesco Ltd. | $375.526 | 60.962 | 0,03% | Aktien |
| FIFTH THIRD BANCORP | $333.595 | 54.155 | 0,03% | Aktien |
| Avidity Partners Management LP | $308.000 | 50.000 | 0,03% | Aktien |
| Sivia Capital Partners, LLC | $298.760 | 48.500 | 0,02% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $293.450 | 47.638 | 0,02% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $285.824 | 46.400 | 0,02% | Verkaufsoption |
| PROFUND ADVISORS LLC | $285.645 | 46.371 | 0,02% | Aktien |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | $283.360 | 46.000 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $280.003 | 45.455 | 0,02% | Aktien |
| Jump Financial, LLC | $273.504 | 44.400 | 0,02% | Aktien |
| SEI INVESTMENTS CO | $267.523 | 43.429 | 0,02% | Aktien |
| CITADEL ADVISORS LLC | $256.872 | 41.700 | 0,02% | Verkaufsoption |
| Police & Firemen's Retirement System of New Jersey | $250.324 | 40.637 | 0,02% | Aktien |
| JANUS HENDERSON GROUP PLC | $247.018 | 45.200 | 0,02% | Aktien |
Unternehmensinsider 59 Insider · 30 Führungskräfte · 25 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Matthew Pauls | CHIEF EXECUTIVE OFFICER | 16. Dezember 2025 G | 1.188.050 | 0 | 0 | $0 |
| Robert N Neville | Chief Executive Officer | 20. Dezember 2019 A | 498.028 | 0 | 0 | $0 |
| Brian M Culley | CEO and Director | 20. Januar 2017 A | 34.500 | 0 | 0 | $0 |
| Evan Levine | CEO & President | 8. Februar 2008 P | 4.395.000 | 0 | 0 | $0 |
| Nicholas J Virca | CEO and President | 15. Dezember 2003 X | 347.956 | 0 | 0 | $0 |
| David L Lowrance | Chief Financial Officer | 22. Juni 2026 M | 536.032 | 0 | 1 | $-2.240.919 |
| Brandi Roberts | Chief Financial Officer & SVP | 20. Januar 2017 A | 38.000 | 0 | 0 | $0 |
| Gregory P Hanson | Senior VP, CFO & Treasurer | 20. Dezember 2006 A | — | 0 | 0 | $0 |
| Carrie Carlander | CFO, Treas, Secy, VP Finance | 31. Januar 2006 A | 25.000 | 0 | 0 | $0 |
| Jaakko Taneli Jouhikainen | President and Chief Operating Officer | 20. Dezember 2019 A | 167.569 | 0 | 0 | $0 |
| Patrick L Keran | President & COO | 2. Januar 2015 A | — | 0 | 0 | $0 |
| James A Merritt | President & Chf Med Officer | 12. Januar 2007 A | — | 0 | 0 | $0 |
| Robert Matthew Lutz | Chief Fin. & Operating Officer | 15. Juli 2026 A | 328.977 | 0 | 0 | $0 |
| Kathleen R. Mccabe | Chief Legal Officer | 14. Dezember 2025 F | 519.232 | 0 | 0 | $0 |
| Anne Erickson | Chief Business Officer | 14. Dezember 2025 F | 371.712 | 0 | 0 | $0 |
| Yasmine Wasfi | Chief Medical Officer | 4. Dezember 2025 F | 168.008 | 0 | 0 | $0 |
| Braden C. Parker | Chief Commercial Officer | 12. Dezember 2024 A | 105.000 | 0 | 0 | $0 |
| Raymond Dennis Pratt | Chief Medical Officer | 12. Dezember 2024 A | 340.050 | 0 | 0 | $0 |
| Badrul A. Chowdhury | CHIEF MEDICAL OFFICER | 14. Dezember 2021 A | 300.000 | 0 | 0 | $0 |
| Shana Hood | General Counsel & VP | 20. Januar 2017 A | — | 0 | 0 | $0 |
| Edwin L. Parsley | Chief Medical Officer & SVP | 20. Januar 2017 A | — | 0 | 0 | $0 |
| Gregory D. Gorgas | Senior VP, Commercial | 4. Januar 2016 A | — | 0 | 0 | $0 |
| Robert Martin Emanuele | Senior VP, Development | 4. Januar 2016 A | 294.598 | 0 | 0 | $0 |
| Santosh Vetticaden | Chief Medical Officer & SVP | 19. Juni 2014 A | — | 0 | 0 | $0 |
| Mark E. Erwin | SVP, Operations | 30. Januar 2009 A | — | 0 | 0 | $0 |
| Michele Yelmene | VP, Regulatory & QA | 30. Januar 2009 A | — | 0 | 0 | $0 |
| Joachim Ph Schupp | VP, Medical Affairs | 31. März 2008 A | — | 0 | 0 | $0 |
| Joan M Robbins | SVP & Chief Science Officer | 31. März 2008 A | 146.500 | 0 | 0 | $0 |
| Mark Joseph Cantwell | VP, Research & Development | 12. Januar 2007 A | — | 0 | 0 | $0 |
| Cellia Habita | Senior VP, Clinical & Medical | 7. Oktober 2004 P | 5.000 | 0 | 0 | $0 |
| Joseph S Mccracken | Direktor | 16. Februar 2026 M | 302.644 | 0 | 0 | $0 |
| David A Ramsay | Direktor | 19. Dezember 2025 S | 2.533.642 | 0 | 1 | $-121.200 |
| An Van Es-Johansson | Direktor | 9. Dezember 2025 A | 102.500 | 0 | 0 | $0 |
| Nevan C Elam | Direktor | 9. Dezember 2025 A | 106.887 | 0 | 0 | $0 |
| Richard J Hawkins | Direktor | 9. Dezember 2025 A | 161.326 | 0 | 0 | $0 |
| Ricky Sun | Direktor | 14. Dezember 2023 A | 22.500 | 0 | 0 | $0 |
| Yuri Pikover | Direktor | 13. Dezember 2018 A | 153.734 | 0 | 0 | $0 |
| Peter Greenleaf | Direktor | 20. Januar 2017 A | — | 0 | 0 | $0 |
| DITTRICH HOWARD | Direktor | 20. Januar 2017 A | — | 0 | 0 | $0 |
| Lewis Shuster | Direktor | 11. Juni 2015 A | — | 0 | 0 | $0 |
| Jack Lief | Direktor | 11. Juni 2015 A | — | 0 | 0 | $0 |
| Ted W Love | Direktor | 19. Juni 2013 A | — | 0 | 0 | $0 |
| Odysseas D Kostas | Direktor | 30. Juni 2010 A | — | 0 | 0 | $0 |
| Eric K Rowinsky | Direktor | 30. Juni 2010 A | — | 0 | 0 | $0 |
| Mark Jerome Pykett | Direktor | 30. Juni 2010 A | 8.000 | 0 | 0 | $0 |
| Michael M Goldberg | Direktor | 30. Juni 2010 A | 26.000 | 0 | 0 | $0 |
| DENNER ALEXANDER J | Direktor | 30. Juni 2008 A | — | 0 | 0 | $0 |
| Mark Bagnall | Direktor | 23. Mai 2007 A | — | 0 | 0 | $0 |
| Ross M Johnson | Direktor | 21. Dezember 2006 X | 1.621.779 | 0 | 0 | $0 |
| Meister, Keith A. | Direktor | 2. Juni 2006 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC, New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×4 Einreichungen | 14. November 2025 | 12,00% | Änderung | Passive Anlage | SEC |
| Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP ×5 Einreichungen | 27. März 2025 | 9,99% | Änderung | — | SEC |
| High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn | 30. Dezember 2015 | — | Erste Einreichung | — | SEC |
| Evan M. Levine, Mark Capital, LLC | 6. Februar 2009 | — | Erste Einreichung | — | SEC |
| Evan Levine, Mark Capital, LLC ×2 Einreichungen | 19. Dezember 2007 | — | Erste Einreichung | — | SEC |
| Matthew Balk ×2 Einreichungen | 1. Juni 2006 | — | Erste Einreichung | Passive Anlage | SEC |
| High River Limited Partnership S.S. OR, Hopper Investments LLC S.S. OR, Barberry Corp. S.S. OR, Icahn Partners Master Fund LP S.S. OR, Icahn Offshore LP S.S. OR, CCI Offshore Corp. S.S. OR, Icahn Partners LP S.S. OR, Icahn Onshore LP S.S. OR, CCI Onshore Corp. S.S. OR, Carl C. Icahn S.S. OR | 5. August 2005 | — | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 38 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3,22% | 651.024 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,56% | 39.885 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,21% | 203.377 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,20% | 519.481 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 301.950 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 11.152 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 163.980 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,06% | 1.401.936 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,05% | 7.524 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,05% | 777.564 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 880.662 SH | 8. August 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,03% | 70.061 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 3.921.924 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 62.952 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 105.661 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,02% | 6.895 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 33.621 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 646.784 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 5.393 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.567.813 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 277.850 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,01% | 11.041 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,01% | 4.332 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 5.454 NS | 31. Mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,01% | 12.910 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 9.739 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 31.710 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 5.605 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 18.178 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 80.699 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 137 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 42.652 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 170.824 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 80.211 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 23.796 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1.747 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 6.164.961 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.396 SH | 8. August 2026 | Täglich |